Eske Kvanner Aasvang
Papers
5
Total Citations
71
H-Index
2
About
Eske Kvanner Aasvang is a leading clinical researcher in surgical oncology and perioperative medicine, with a primary focus on comparing open versus robot-assisted surgical techniques for bladder and gastroesophageal cancers. His most impactful work centers on the BORARC trial—a double-blinded, randomised feasibility study examining outcomes in radical cystectomy. This landmark investigation, with over 40 citations, demonstrated that blinding patients and care providers to surgical technique is feasible, setting a new standard for unbiased surgical research. Aasvang’s contributions extend to evaluating quality of life, haemodynamic stability, and respiratory outcomes, showing that robot-assisted cystectomy with steep Trendelenburg positioning and CO₂ pneumoperitoneum does not compromise immediate postoperative recovery. His 2022 study on secondary outcomes (25 citations) further clarified patient-reported benefits. More recently, he has explored gastric conduit perfusion during robot-assisted gastroesophageal cancer resection, challenging assumptions about right gastric artery ligation. Aasvang’s methodologically rigorous, double-blinded designs have advanced evidence-based surgery, influencing how perioperative care is evaluated. His work is essential reading for researchers and clinicians seeking to understand the true comparative effectiveness of minimally invasive versus open oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5